Frost & Sullivan Lauds BioScale for Developing a Revolutionary Protein Analysis Platform Based on its ViBE Platform

Frost & Sullivan Lauds BioScale forFrost & Sullivan Lauds BioScale for Developing a Revolutionary Protein Analysis Platform Based on its ViBE Platform PR Newswire MOUNTAIN VIEW, California, Jan. 22, 2014 - The ViBE addresses limitations with traditional technologies such as ELISA, western blot and IHC and enables the measurement of low- expressing proteins, which were inaccessible through other techniques available in the market Based on its recent analysis of the protein analysis market, Frost & Sullivan recognizes BioScale, Inc. with the North America Frost & Sullivan Award for New Product Innovation. BioScale has reduced the bottlenecks and limitations common in conventional protein analysis technologies by developing a fast, simple, ultra-sensitive, and flexible technology. Its revolutionary ViBE platform is rapidly gaining traction among pharmaceutical companies and high-profile academic and government laboratories, and is proving to be a market-changing technology with a wide scope of applications. BioScale's ViBE protein measurement technology platform provides highly-sensitive, robust, and reproducible protein detection and quantitation in a fully-automated walk-away instrument. The system is powered by the company's proprietary Acoustic Membrane MicroParticle (AMMP) technology, which combines magnetic microparticle analyte captured with microelectromechanical systems (MEMS) sensors for non- optical acoustic detection.